10x Genomics (TXG) earnings per share (EPS)

Earnings per share · fiscal 2025
-$0.35

10x Genomics (TXG) reported diluted earnings per share of -$0.35 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.52. Figures as of 17 Nov 2026, 21:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$0.35
Highest on record
-$0.35fiscal 2025
Lowest on record
-$5.37fiscal 2020
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

10x Genomics earnings per share (EPS), in more detail

Across the 7 fiscal years on record (2019–2025), the highest was -$0.35 in fiscal 2025 and the lowest -$5.37 in fiscal 2020.

History · 7 fiscal years

Earnings per share by fiscal year

10x Genomics earnings per share (EPS), year by year

10x Genomics (TXG) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$0.35—
2024-$1.52—
2023-$2.18—
2022-$1.46—
2021-$0.53—
2020-$5.37—
2019-$0.80—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of 10x Genomics and comparable companies
CompanyEarnings per shareFiscal year
Twist Bioscience TWST-$1.302025
Protagonist Therapeutics PTGX-$2.052025
Krystal Biotech KRYS$6.842025
10x Genomics TXG-$0.352025
HealthEquity HQY$2.462026
Corcept Therapeutics CORT$0.822025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics earnings per share (EPS): questions and answers

What is 10x Genomics's diluted earnings per share?

10x Genomics (TXG) reported diluted earnings per share of -$0.35 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.52.

What are the highest and lowest diluted earnings per share figures on record for 10x Genomics?

Across the 7 fiscal years on record (2019–2025), the highest was -$0.35 in fiscal 2025 and the lowest -$5.37 in fiscal 2020.

How is 10x Genomics's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/TXG/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.